ESC: Reports Conflict on Clopidogrel Response Genetics

MedPage Today -- Genetic variants that have been associated with reduced clopidogrel (Plavix) efficacy and increased cardiovascular events were not related to rates of major cardiovascular events in a substudy of a randomized clinical trial.